A bid to limit access to the abortion drug mifepristone is being considered by a US appeals court. The Republican-led state of Louisiana is seeking to block a 2023 rule that permits the medication to be prescribed via telemedicine.

The court appears skeptical of this bid. Further details about the court's consideration and the potential impact on access to mifepristone are available from the source.

The case involves a challenge to the rule allowing telemedicine prescriptions for the abortion drug. For more information, readers can refer to the original source.